GSK & Sanofi Back for a Phase 2 Vaccine Trial in U.S., Honduras & Panama Financed by U.S. Gov
Two major European pharmaceutical manufacturers, France-based Sanofi and UK-based GlaxoSmithKline (GSK) found setbacks toward the end of 2020 with an […]
Germany’s CureVac Raises $450m While Announcing $180.3m Deal with GSK to Partner up on mRNA-based Vaccine Co-Development, Manufacturing & Commercialization
Germany-based CureVac, the global biopharmaceutical company developing novel transformative medicines based on messenger ribonucleic acid (“mRNA), including a high potential […]
Vir Biotechnology & GSK’s Candidate Monoclonal Antibody Candidate Enters NIH-Sponsored ACTIV-3 Phase 3 Study: First Dosing
A San Francisco-based infectious disease-focused biotech called Vir Biotechnology (Nasdaq: VIR)(Vir) teamed with UK-based pharmaceutical giant GlaxoSmithKline (LSE/NSE:GSK) to inform […]
Clinical Trials and Research Roundup | Doctors: Ivermectin Can Help Treat COVID: Will Anyone Listen?
Introducing the Physicians for Civil Defense: Prominent Doctors Know #Ivermectin can Help Treat COVID-19: Will Anyone Listen?A group calling […]
GSK & Vir Biotechnology Commence Phase 2/3 Monoclonal Antibody Targeting COVID-19 Patients: Compete Against Regeneron & Lilly
Publicly traded Vir Biotechnology (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) announced the first patient was dosed in a Phase […]
GlaxoSmithKline Vaccine Division Allegedly Raided by Korean Authorities
Korean prosecutors have raided GlaxoSmithKline’s (GSK) vaccine division offices according to inside reporting. Although not public, speculation centers on an […]
Sanofi & GSK Ink LOI to Commence COVID-19 Vaccine Collaboration: Finished Good Projected for 14+ Months Away
European pharmaceutical giants recently inked a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from […]
GSK Injects $250m into Vir in Collaborative Pact to Develop COVID-19 Treatments
Leveraging its capital, global reach, and functional genomics expertise, GlaxoSmithKline will inject $250 million into Vir Biotechnology, and its proprietary […]
GSK Taps UC Berkeley’s CRISPR Expertise to Accelerate Drug Development
GlaxoSmithKline (GSK) announced a five-year collaboration with UC Berkeley and UCSF to establish a laboratory where state-of-the-art CRISPR techniques will […]
Adverse Event: GSK’s Belimumab Increased Risk of Serious Psychiatric Events Seen in Clinical Trials
The UK government reported that GSK’s Belimumab (Benlysta) have revealed in clinical trials to show an increased risk of depression, […]
